Akèy › Maladi Crohn › Massachusetts › Boston
Etid klinik pou Maladi Crohn nan Boston, MA
19 etid pou Maladi Crohn ap chèche patisipan nan sit nan ak bò kote Boston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Ap rekriteFaz 3
- Massachusetts General Hospital-Crohn's and Colitis Center ( Site 5037), Boston
Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance
Ap rekriteVolontè an sante akeyi
- Massachusetts General Hospital, Boston
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 3
- Boston Childrens Hospital, Boston
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Ap rekriteFaz 1
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 3
- Tufts Medical Center-Site Number: 8400126, Boston
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Ap rekriteFaz 3
- Boston Children's Hospital, Boston
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
Ap rekriteFaz 3
- Boston Children's Hospital, Boston
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
Ap rekriteEtid obsèvasyon
- Brigham and Women's Hospital, Boston
Low Dose IL-2 for the Treatment of Crohn's Disease
Ap rekriteFaz 1/2
- Boston Children's Hospital, Boston
- Brigham and Women's Hospital, Boston
Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 3
- Boston Children's Hospital /ID# 262191, Boston
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
Ap rekriteFaz 4
- Boston Children's Hospital, Boston
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
Ap rekriteFaz 3
- Boston Children's Hospital, Boston
A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
Ap rekriteFaz 2
- Investigational Site Number: 8400022, Boston
Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.
Ap rekriteEtid obsèvasyon
- Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown · 1 mi lwen
Personalized Risk Estimation for Crohn's Disease (PRE-Crohn's): Implementation and Feasibility
Ap rekriteVolontè an sante akeyi
- Massachusetts General Hospital, Boston
A Study for Imaging the Lower Gastrointestinal Tract Using a Retro-TCE Capsule
Ap rekriteVolontè an sante akeyi
- Massachusetts General Hospital, Boston
Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Boston Children's Hospital, Boston
High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy
Ap rekriteEtid obsèvasyon
- Boston Children's Hospital, Boston
Family Members At INcreased-risk for Developing Inflammatory Bowel Disease
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Massachusetts General Hospital, Boston
Etid Maladi Crohn nan lòt vil
- New York City, NY35 etid
- Cleveland, OH19 etid
- St. Louis, MO19 etid
- Miami, FL19 etid
- Orlando, FL17 etid
- Houston, TX17 etid
- Atlanta, GA17 etid
- Tyler, TX16 etid
- San Diego, CA15 etid
- San Antonio, TX15 etid
- Los Angeles, CA15 etid
- Philadelphia, PA13 etid
Lòt etid nan Boston
- Kansè nan tete111 etid
- Kansè Poumon ki pa ti selil90 etid
- Kansè (tout kalite)86 etid
- Kansè kolorektal63 etid
- Kansè Metastatik63 etid
- Kansè poumon62 etid
- Kansè ovè61 etid
- Kansè pwostat59 etid
- Depresyon52 etid
- Kansè Endomèt50 etid
- Ensifizyans kadyak44 etid
- Leksemi mieloïd egi44 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.